A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
This study describes a representative collection of well-characterized BC organoids available for cancer research and drug development, as well as a strategy to assess in vitro drug response in a personalized fashion. Graphical abstract Teaser The heterogeneity of breast cancer subtypes can be captured using organoid cultures that can facilitate drug screens that corroborate with patient responses.
Source: Cell - Category: Cytology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cytology | Epithelial Cancer | Genetics | HER2 | Hormones | Study | Transplants